Cancer Immunotherapy Trials Networks
Providing Access to Promising Therapies to People With Cancer
The Cancer Immunotherapy Trials Network (CITN) and affiliated Immune Oncology Network (ION) strive to make promising experimental immunotherapies broadly available to people with cancer. CITN and ION benefit from the collective expertise of top academic immunologists to conduct multicenter research on immunotherapy agents capable of unleashing patient immunity to fight cancer.
What We Do
We conduct studies of experimental cancer immunotherapies and focus on testing novel agents in innovative, early-phase clinical trials.
Who We Are
The collective expertise of top academic immunologists at member clinics in North America come together to support the work of CITN and ION.
Who We Help
Our clinical trials provide critical data that helps move the science forward toward potential therapies from experimental stages to wide-spread use for treating patients with cancer.
Cancer Trials Support Network
The Cancer Trials Support Unit is a service of the National Cancer Institute designed to facilitate access to NCI-funded clinical trials for qualified sites and to support the management and conduct of those trials.